4
Changes in Ownership
Trevi Therapeutics, Inc. Filed Acc 0000950170-24-064598
Chief Financial Officer sold 4,350 shares at $2.64 ($11,485)
- Chief Financial Officer acquired 16,043 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Delfini Lisa · Chief Financial Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-05-22 | Exercise or conversion : show line 1 in the form | +16,043 | $0.51 | $8,198 | 57,629 | D |
| 2024-05-22 | Sale : show line 2 in the form | −4,350 | $2.64 | $11,485 | 53,279 | D |
| Open-market sales · 4,350 sh · avg $2.64 · $11,485 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-05-22 | Exercise or conversion : show line 3 in the form Stock Option (right to buy) | −16,043 | 48,125 | D |
Loading xslF345X05/ownership.xml…